Seres Therapeutics
MCRB
#10246
Rank
โ‚ฌ2.85 M
Marketcap
0,33ย โ‚ฌ
Share price
1.11%
Change (1 day)
-61.49%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -โ‚ฌ0.13 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ85.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ0.12 Billion34.63%
2023 -โ‚ฌ85.53 Million-59.97%
2022 -โ‚ฌ0.22 Billion289.57%
2021 -โ‚ฌ54.85 Million-27.3%
2020 -โ‚ฌ75.45 Million23%
2019 -โ‚ฌ61.34 Million-30.11%
2018 -โ‚ฌ87.77 Million9.73%
2017 -โ‚ฌ79.99 Million-0.74%
2016 -โ‚ฌ80.59 Million70.96%
2015 -โ‚ฌ47.14 Million257.11%
2014 -โ‚ฌ13.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.22 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.23 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.38 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA